ARCHIVES

ODAC Recommends Fludarabine Approval for Refractory CLL

This article is from The Cancer Letter archive.

Vol. 16 No. 36 | September 21, 1990

Download PDF Visit The Full Archive

Related Articles

Survivorship Research RFA To Be Reissued; Biomedical Imaging Institute Names 10 to Advisory Council

November 29, 2002

In Brief: Deisseroth Leaves M.D. Anderson To Head Yale’s Oncology, Gene Therapy Programs

September 15, 1995

AACR Presents 2014 Awards, Arteaga Becomes President at Annual Meeting

April 11, 2014

CAP Issues Active Surveillance Guidance For Prostate Cancer

September 5, 2014

FTC Report Disagrees With Key Provision Of Biologics Bill Backed By Companies

June 12, 2009

DCPC Concepts Approved For Tw Grants Support Contract

January 31, 1986